A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants-Reference-Cited by-同舟云学术

A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants

Published:2021-08-24 Issue:11 Volume:17 Page:4646-4653
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Cohet Catherine¹^ORCID,Cheuvart Brigitte¹^ORCID,Moerman Leentje¹,Bi Dan¹^ORCID,Caplanusi Adrian¹,Kariyappa Mallesh²,Lalwani Sanjay³,Mitra Monjori⁴,Sapru Amita⁵,Saha Shruti⁶,Varughese P.V.⁷,Kompithra Rajeev Zachariah⁸^ORCID,Gandhi Sanjay⁹

Affiliation:

1. GSK Wavre, Belgium

2. Department of Pediatrics, Bangalore Medical College & Research Institute, Vani Vilas Women and Children Hospital, Bangalore, India

3. Bharati Vidyapeeth Deemed University Hospital, Pune, India

4. Department of Pediatrics, Institute of Child Health, Kolkata, India

5. Department of Pediatrics, KEM Hospital Research Centre, Pune, India

6. Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, India

7. Department of Pediatrics, Christian Medical College, Ludhiana, India

8. Well Baby Immunisation Clinic, Department of Pediatrics, Unit I, Christian Medical College, Vellore, India

9. GSK, Mumbai, India

Funder

GlaxoSmithKline Biologicals